These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 447829)

  • 1. Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein.
    Zapf J; Schoenle E; Jagars G; Sand I; Grunwald J; Froesch ER
    J Clin Invest; 1979 May; 63(5):1077-84. PubMed ID: 447829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo.
    Kaufmann U; Zapf J; Torretti B; Froesch ER
    J Clin Endocrinol Metab; 1977 Jan; 44(1):160-6. PubMed ID: 833254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of insulin and NSILA on adipocytes of normal and diabetic rats: receptor binding, glucose transport and glucose metabolism.
    Schoenle E; Zapf J; Froesch ER
    Diabetologia; 1977 May; 13(3):243-9. PubMed ID: 141388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor binding and effects of insulin and NSILA-S on glucose transport and metabolism in adipocytes from hypophysectomized rats.
    Schoenle E; Zapf J; Froesch ER
    Diabetologia; 1979 Jan; 16(1):41-6. PubMed ID: 761737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NSILA-carrier protein abolishes the action of nonsuppressible insulin-like activity (NSILA-S) on perfused rat heart.
    Meuli C; Zapf J; Froesch ER
    Diabetologia; 1978 Apr; 14(4):255-9. PubMed ID: 640301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of serum nonsuppressible insulin-like activity (NSILA) in wound healing. I. Influence of thyroparathyroidectomy on serum NSILA and wound healing in the rat.
    Poffenbarger PL; Haberal MA
    Surgery; 1976 Nov; 80(5):608-16. PubMed ID: 982280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Insulin receptors-a review (author's transl)].
    Freychet P
    Diabete Metab; 1975 Mar; 1():57-68. PubMed ID: 791721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similarities between the insulin-like stimulatory effect of human IgG and NSILP.
    Khokher MA; Taylor AM; Dandona P
    Diabetes Res; 1986 Sep; 3(7):373-6. PubMed ID: 3096625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsuppressible insulinlike activity (NSILA) and the glucose dyshomeostasis of agonal sepsis.
    Viray RE; Filkins JP
    Adv Shock Res; 1983; 9():31-41. PubMed ID: 6349307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsuppressible insulin-like activity of human serum. A potent inhibitor of insulin degradation.
    Kahn CR; Megyesi K; Roth J
    J Clin Invest; 1976 Feb; 57(2):526-9. PubMed ID: 1254732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a specific inhibitor of nonsuppressible insulin-like activity in a partially purified human serum fraction.
    Herington AC; Kuffer AD
    Endocrinology; 1981 Nov; 109(5):1634-40. PubMed ID: 7297496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-suppressible insulin-like serum activity (NSILA). Physiological importance and survey of the current state of research].
    Zapf J
    Fortschr Med; 1980 Jan; 98(2):66-8. PubMed ID: 7364359
    [No Abstract]   [Full Text] [Related]  

  • 13. The purification and partial characterization of an insulin-like protein from human serum.
    Poffenbarger PL
    J Clin Invest; 1975 Dec; 56(6):1455-63. PubMed ID: 1202080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of serum nonsuppressible insulin-like activity (NSILA) in compensatory renal growth.
    Poffenbarger PL; Prince MJ
    Growth; 1976 Mar; 40(1):83-97. PubMed ID: 177337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the biological activity of insulin, cyclic nucleotides and concanavalin A in the isolated fat cell.
    Solomon SS; King LE; Hashimoto K
    Horm Metab Res; 1975 Jul; 7(4):297-304. PubMed ID: 168139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation between carrier-bound forms of non-suppressible insulin-like activity (NSILA) in serum.
    Cornell HJ; Bistrin M; Herington AC
    Int J Biochem; 1985; 17(9):1003-8. PubMed ID: 4065403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin and nonsuppressible insulin-like activity (NSILA-S) stimulate the same glucose transport system via two separate receptors in rat heart.
    Meuli C; Froesch ER
    Biochem Biophys Res Commun; 1977 Apr; 75(3):689-95. PubMed ID: 193498
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent investigation of the nature of nonsuppressible, acid ethanol soluble insulin-like activity (NSILA-S).
    Labhart A; Oelz O; Bünzli HF; Humbel RE; Ritschard WJ; Froesch ER
    Isr J Med Sci; 1972 Jun; 8(6):901-2. PubMed ID: 5051836
    [No Abstract]   [Full Text] [Related]  

  • 19. Preferential association of the insulin-like growth factors I and II with metabolically inactive and active carrier-bound complexes in serum.
    Cornell HJ; Enberg G; Herington AC
    Biochem J; 1987 Feb; 241(3):745-50. PubMed ID: 3593220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplication-stimulating activity (MSA): a somatomedin-like polypeptide from cultured rat liver cells.
    Nissley SP; Rechler MM
    Natl Cancer Inst Monogr; 1978 May; (48):167-77. PubMed ID: 748750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.